New York A 9252: Establishes a grant program to assist providers in purchasing opioid antagonists alongside automated external defibrillators

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A09252 Summary:

BILL NOA09252 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORDais

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

Amd §3000-b, add §3000-g, Pub Health L; add §99-tt, St Fin L

&nbsp

Establishes a grant program to assist providers in purchasing opioid antagonists alongside automated external defibrillators; establishes criteria for such grant program.

Go to top A09252 Actions:

BILL NOA09252 

&nbsp

11/21/2025referred to health

01/07/2026referred to health

Go to topA09252 Committee&nbspVotes:

Go to topA09252 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA09252 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 9252

 2025-2026 Regular Sessions

 IN ASSEMBLY

 November 21, 2025
 ___________

 Introduced by M. of A. DAIS -- read once and referred to the Committee
 on Health

 AN ACT to amend the public health law and the state finance law, in
 relation to requiring opioid antagonists to be stored with all auto-
 mated external defibrillators in the state of New York and establish-
 ing a grant program to accomplish such goal

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Legislative findings. The legislature finds that opioid
 2 overdoses continue to be a leading cause of preventable death in the
 3 State of New York. Immediate access to opioid antagonists, such as
 4 naloxone nasal spray, can prevent fatalities and save lives. Automated
 5 external defibrillators are strategically located in many public places
 6 and emergency response settings. By mandating that automated external
 7 defibrillator units also include opioid antagonists, New York state will
 8 better equip bystanders and first responders to address both cardiac and
 9 opioid-related emergencies, thus improving public safety and public
 10 health outcomes.
 11 § 2. Paragraph (c) of subdivision 1 of section 3000-b of the public
 12 health law, as added by chapter 552 of the laws of 1998, is amended to
 13 read as follows:
 14 (c) "Public access defibrillation provider" means a person, firm,
 15 organization or other entity possessing or operating an automated
 16 external defibrillator pursuant to a collaborative agreement under this
 17 section or public buildings, schools, transportation hubs, places of
 18 public assembly, and other locations as designated by the commissioner.
 19 § 3. Subdivision 4 of section 3000-b of the public health law is
 20 renumbered subdivision 5 and a new subdivision 4 is added to read as
 21 follows:
 22 4. Opioid antagonists. (a) All public access defibrillation providers
 23 shall cause the automated external defibrillator to also contain at
 24 least one dose of an opioid antagonist, including but not limited to
 25 naloxone nasal spray.

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD13975-01-5

 A. 9252 2

 1 (b) The commissioner shall promulgate rules and regulations establish-
 2 ing minimum requirements for storage, labeling, replacement, training,
 3 and maintenance of opioid antagonists co-located with the automated
 4 external defibrillator units.
 5 (c) All public access defibrillation providers shall also be responsi-
 6 ble for the maintenance and timely replacement of opioid antagonists,
 7 including expiration date tracking and proper storage.
 8 (d) The department shall make available training resources for the
 9 administration of opioid antagonists, including digital and on-site
 10 formats, in conjunction with existing automated external defibrillator
 11 training requirements.
 12 § 4. The public health law is amended by adding a new section 3000-g
 13 to read as follows:
 14 § 3000-g. Public access defibrillation provider opioid antagonist
 15 grant program. 1. There is hereby established a public access defibril-
 16 lation provider opioid antagonist grant program to be administered by
 17 the department.
 18 2. The purpose of such program shall be to provide an incentive and
 19 financial assistance to public access defibrillation providers who are
 20 seeking to obtain opioid antagonists alongside automated external defi-
 21 brillator units.
 22 3. The department shall set criteria for eligibility